Acute myeloid leukaemia trials in China

In China 226 Also abroad 763

226 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

Phase 2Not yet taking people in China
IFN-α in Relapse Prevention.
Where
Beijing
Age
12 years to 65 years
People
100
Run by
Peking University People's Hospital
See details and how to joinNCT07449286
Phase 2Taking people
Venetoclax and Azacitidine Combined With Homoharringtonine, Followed by Allo-HSCT for Intermediate and High-risk AML.
Where
Shanghai
Age
18 years to 55 years
People
56
Run by
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT06483906
Phase 1Not yet taking people in China
A Clinical Study to Explore the Safety and Efficacy of CT1390B in Relapsed/ Refractory Acute Myeloid Leukemia
Where
Tianjin
Age
18 years to 70 years
People
18
Run by
Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT07441980
Phase 1/2Taking people
Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors
Where
Beijing
Age
8 years to 85 years
People
85
Run by
Essen Biotech
See details and how to joinNCT07410494
No phaseTaking people
National Longitudinal Cohort of Hematological Diseases
Where
Tianjin
People
2,300
Run by
Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT04645199
Phase 2Taking people
Alternating Regimen of VA and Low-dose CHA in the Treatment of Unfit Newly Diagnosed AML
Where
Beijing, Hangzhou, Nanchang, Shenzhen, Suzhou
Age
18 years and over
People
25
Run by
First Affiliated Hospital of Zhejiang University
See details and how to joinNCT07172204
Phase 2Taking people
Gilteritinib Plus VA Followed By Consolidation Chemotherapy in Newly Diagnosed FLT3-ITD+ AML
Where
Hangzhou
Age
18 years to 59 years
People
25
Run by
First Affiliated Hospital of Zhejiang University
See details and how to joinNCT07259707
Phase 1Taking people
Romiplostim N01 for Platelet Recovery After Haploidentical HSCT
Where
Hangzhou
Age
18 years and over
People
130
Run by
First Affiliated Hospital of Zhejiang University
See details and how to joinNCT07321626
Phase 1/2Not yet taking people in China
Clinical Study of Anti-CLL1-CD33-NKG2D Bicephali CAR-T for Relapsed/Refractory Acute Myeloid Leukemia
Where
Xuzhou
Age
18 years to 70 years
People
20
Run by
Xuzhou Medical University
See details and how to joinNCT07370064
Phase 1Taking people
A Phase 1 Study of CG009301 for Injection in Adult Subjects With Recurrent or Refractory Haematological Malignancies
Where
Nanchang, Tianjin, Wuhan
Age
18 years to 75 years
People
45
Run by
Cullgen (Shanghai),Inc
See details and how to joinNCT07347171
No phaseNot yet taking people in China
Safety and Efficacy of CLL1 CAR-T Followed by Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia
Where
Wuhan
Age
18 years to 78 years
People
18
Run by
Donghua Zhang
See details and how to joinNCT07342244
No phaseTaking people
Using Multiparametric Flow Cytometry to Detect Peripheral Blood and Bone Marrow Leukaemia Stem Cells for Relapse Prediction in P-AML
Where
Beijing
Age
Up to 18 years
People
283
Run by
Peking University People's Hospital
See details and how to joinNCT06452732
No phaseTaking people
Safety and Feasibility of Sulforaphane to Promote Early Haematopoietic Recovery After Cord Blood Transplantation
Where
Tianjing
Age
18 years and over
People
36
Run by
Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT07297576
Phase 2Taking people
CAV Regimen for R/R AML
Where
Suzhou
Age
16 years to 70 years
People
68
Run by
The First Affiliated Hospital of Soochow University
See details and how to joinNCT05657639
Phase 2Taking people
Post-transplantation Maintenance Therapy With Cidabenamide in Patients With Intermediate/High-risk AML
Where
Harbin, Shijiazhuang, Tianjin
Age
18 years to 75 years
People
134
Run by
Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT07304232
Phase 1/2Taking people
SupCD7 CART for Relapsed or Refractory CD7 Positive Hematologic Malignancies
Where
Tianjin
Age
18 years to 70 years
People
12
Run by
Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT07153068
Phase 1Taking people
Clinical Study of LILRA6 CAR-T for the Treatment of R/R Acute Myeloid Leukemia
Where
Hangzhou
Age
18 years to 75 years
People
48
Run by
Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT07263906
Phase 3Taking people
A Pivotal Study of APG-2575 (Lisaftoclax) Combined With Azacitidine in the Treatment of Acute Myeloid Leukemia
Where
Hangzhou, Tianjin
Age
18 years and over
People
486 worldwide
Run by
Ascentage Pharma Group Inc.
See details and how to joinNCT06389292 · EU 2024-516436-10-00
Phase 2Taking people
Venetoclax and Azacitidine Combined With Chidamide (VAC) for the Treatment of Newly Diagnosed Acute Monocytic Leukemia
Where
Suzhou
Age
18 years and over
People
92
Run by
The First Affiliated Hospital of Soochow University
See details and how to joinNCT05566054
Phase 2Taking people
Comparison of VA (Venetoclax, Azacitidine), VACl (VA, Cladribine), VACh (VA, Chidamide), and Alternating VACl/VACh in Newly Diagnosed Acute Myeloid Leukemia
Where
Suzhou
Age
18 years and over
People
172
Run by
The First Affiliated Hospital of Soochow University
See details and how to joinNCT06532552
No phaseTaking people
Clinical Study to Evaluate the Safety and Efficacy of γδ T Cells for the Prevention of Relapse After Allogeneic Transplantation in Patients With High-risk Acute Myeloid Leukemia
Where
Wuhan
Age
18 years to 65 years
People
40
Run by
Donghua Zhang
See details and how to joinNCT07237230
Phase 1Not yet taking people in China
A Clinical Study to Explore the Safety and Efficacy of CT0991 in Relapsed/ Refractory Acute Myeloid Leukemia
Where
Wuhan
Age
18 years to 75 years
People
24
Run by
MEI HENG
See details and how to joinNCT07233018
Phase 2Taking people
Randomized Study of ABC-14 Regimen Compared With "3+7" Standard Induction Therapy or AB-14 for ND AML
Where
Dongguan, Foshan, Guangzhou, Haikou, Shenzhen, Zhanjiang, Zhuhai
Age
18 years and over
People
240
Run by
Guangdong Provincial People's Hospital
See details and how to joinNCT06451861
No phaseTaking people
High-Altitude Hematology Observation-Stem Cell Transplantation (HALO-SCT)
Where
Xining
People
1,000
Run by
Yigeng Cao,MD,PhD
See details and how to joinNCT07205523
Phase 1Taking people
CLL-1 CAR-NK Cells for Relapsed/Refractory AML
Where
Shanghai
Age
18 years to 70 years
People
24
Run by
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT06307054